NYSE: ABBV
AbbVie Inc. (ABBV) Stock Analysis
AbbVie is a biopharmaceutical company focused on immunology, oncology, and neuroscience. Aphelion AI analyzes ABBV performance.
Company Overview
| Symbol | ABBV |
|---|---|
| Company | AbbVie Inc. |
| Exchange | NYSE |
| Sector | Healthcare |
| Market Cap | $280B |
| CEO | Richard Gonzalez |
| Founded | 2013 |
| Headquarters | North Chicago, IL |
Powered by GPT-4. Technical analysis, fundamentals, and AI insights in one report.
Frequently Asked Questions about ABBV
What does AbbVie Inc. (ABBV) do?
AbbVie is a biopharmaceutical company focused on immunology, oncology, and neuroscience. Aphelion AI analyzes ABBV performance.
Where is ABBV traded?
AbbVie Inc. (ABBV) is traded on the NYSE stock exchange. You can analyze ABBV using Aphelion AI's real-time analysis tools.
How can I analyze ABBV stock?
Aphelion AI provides AI-powered analysis for ABBV including technical indicators, fundamental metrics, earnings data, and sentiment analysis. Simply search for ABBV in our analysis tool for a comprehensive report.
What sector is ABBV in?
AbbVie Inc. operates in the Healthcare sector. You can explore other Healthcare stocks on Aphelion AI's sector page.